Behavioural Science: How to do what's good for us
Human beings always seem to end up doing things we know are bad for us. But why? Where do these motivations lie? Does science and technology have the solution?
To find out, join us on Invent: Health, a podcast brought to you by technology and product development company TTP.
Doing what’s good for you should seem like second nature, so why is it that we as humans so often don’t do things which we know will be effective when it comes to our own health and wellbeing? From difficulties in quitting smoking to the 25% of prescriptions in the UK that are left unfilled, medical non-adherence has profound effects on the health of a population, and it’s also one of the trickiest realms for health practitioners to deal with. How do you literally change someone’s behaviour if they already know they’re doing themselves harm?
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Paul Upham is the Head of Smart Devices at Roche / Genentech and has over 20 years of experience in medical technology and digital health in R&D as well as global marketing and product management roles, including leading the development of the world's first prescription digital therapy for type 2 diabetes, Bluestar, from WellDoc.
https://www.linkedin.com/in/paulupham/
Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.
https://www.linkedin.com/in/danlock/
Dr. Olga Perski is an interdisciplinary scientist working at the intersection of behavioural science and digital health. She is a health psychologist by training and completed her PhD at University College London in 2018, with a thesis on the definition, measurement and promotion of user engagement with digital behaviour change interventions. She is a post-doc in the UCL Tobacco and Alcohol Research Group and a UCL Centre for Behaviour Change Associate. Her work is focused on the development and evaluation of digital interventions for smoking cessation and alcohol reduction.
https://www.olgaperski.com/
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent
Find out on this week's episode of Invent: Health from TTP.
This Week's Guests
Paul Upham is the Head of Smart Devices at Roche / Genentech and has over 20 years of experience in medical technology and digital health in R&D as well as global marketing and product management roles, including leading the development of the world's first prescription digital therapy for type 2 diabetes, Bluestar, from WellDoc.
https://www.linkedin.com/in/paulupham/
Dan Lock is a consultant in psychology and human factors at TTP. A psychologist by background, Dan leads on understanding the users of our products, exploring their motivations and figuring out those design features that translate into long-term adherence to medication.
https://www.linkedin.com/in/danlock/
Dr. Olga Perski is an interdisciplinary scientist working at the intersection of behavioural science and digital health. She is a health psychologist by training and completed her PhD at University College London in 2018, with a thesis on the definition, measurement and promotion of user engagement with digital behaviour change interventions. She is a post-doc in the UCL Tobacco and Alcohol Research Group and a UCL Centre for Behaviour Change Associate. Her work is focused on the development and evaluation of digital interventions for smoking cessation and alcohol reduction.
https://www.olgaperski.com/
The Technology Partnership is where scientists & engineers develop new products & technologies that bring innovation & value to clients.
Find out more about our work here: https://ttp.com/invent
